- Adult substance use disorder treatment gaps by state
- CVS to sell its troubled long-term care pharmacy
- Henry Ford Health reaches milestone in $2.2B expansion: 5 things to know
- Hantavirus’ 42-day problem
- Park Dental Partners earns $62.7M in Q1 revenue
- PeaceHealth Oregon chief executive exits after administrative leave
- Michigan health system adopts panic buttons for home care workers
- Justice Department: Yale medical school discriminated based on race
- Sanford Health raises operating margin to 4.2% in Q1
- 5 numbers making dentists optimistic
- 5 numbers making dentists nervous
- Minnesota system on the brink of closure gets $205M lifeline
- 92% of hospital leaders expect significant financial impact from Medicaid cuts: FTI
- Epic’s market share over the last 5 years
- Where are physicians the most consolidated?
- 10 ASC companies to know
- North Carolina independent physician group inks value-based care partnership
- Class-action lawsuits filed against Delta Dental in 4 states
- Bankruptcy, malpractice and the decline of independence: 10 notes on physician threats
- Mark Cuban’s platform cuts out payers – and ASCs are leading the charge
- New York dentist charged in drug case
- The specialty seeing workforce gaps getting narrower
- Illinois weighs teledentistry bill
- 3 federal bills cracking down on physician practice consolidation
- US drug overdose deaths drop for 3rd consecutive year
- AMA’s recommendations for AI in mental healthcare: 3 things to know
- How SCA Health eliminated agency nursing — and saved millions — by rethinking who it hires
- U.S. Overdose Deaths Fell to Pre-Pandemic Levels in 2025
- New Jersey ASC association elects board members
- Intermountain hospital to open behavioral health center
- Adolescent substance use disorder treatment gaps by state
- ‘Idealized’ workforce training collides with behavioral healthcare realities
- Physician-led group expands outpatient care in Washington state
- 25 behavioral health executive moves to know
- Intermountain lands $20M gift to expand Nevada pediatric behavioral health
- Bipartisan lawmakers reintroduce bill barring PBMs from owning pharmacies
- Epic, Oracle and Cleveland Clinic among companies to joining CMS prior authorization initiative
- Court approves sale of CVS' Omnicare unit to GenieRx Holdings
- Too Little or Too Much Sleep Ages Every Organ in Your Body
- Eli Lilly delivers $50M boost to UNICEF’s pediatric health push
- School Recess Key To Learning, Says The American Academy of Pediatrics
- AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda
- Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
- New Brain Stimulation Technique Improves Parkinson's Symptoms Without Surgery
- Heart Attack Survivors Have Higher Risk Of Brain Decline
- Naming Emotions Can Help Autistic People Cope With Anxiety, Study Finds
- Trump And Kennedy Seek To Relax Safeguards For AI Healthcare Tools
- Trump Demands Medicaid Data for Deportation. Some States Go a Step Further.
- Hantavirus News Roundup: From Céline Gounder of KFF Health News
- License To Deliver: Some Midwives Break the Law To Assist With Home Births
- FDA floats possible approach to repurpose approved drugs under new uses
- Sun recalls US chemotherapy batch, citing glass particle contamination concerns
- Bora snaps up MacroGenics’ manufacturing, CDMO operations for up to $127.5M
- 10 state behavioral health policy updates
- Mood disorders during menopause: A call to recognize and respond
- Dentistry’s biggest players
- Nebraska dentist to retire after 33 years of service
- The key to dental practices operating like a 5-star hotel
- MB2 Dental adds 5 new partners in 2 months
- Salesforce Ventures, Echo Health Ventures back Optura's $17.5M series A to track AI performance
- CMS to withhold $1.3B in Medicaid funds from California, puts state officials on notice about fraud
- BeOne's Venclexta challenger Beqalzi nets FDA approval as first BCL-2 for mantle cell lymphoma
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- New payer-backed ad campaign pushes for No Surprises Act IDR reform
- Viz.ai launches AI-powered pulmonary care platform
- Docs more burned out, skeptical of AI than nurses, survey report finds
- As Trump arrives in China, Big Pharma CEOs are notably absent
- Remarks at the MFA Legal & Compliance 2026 Conference
- CMS pauses hospice, home health Medicare enrollments in fraud crackdown
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- Chromie Health picks up $2M in pre-seed funding, launches SMS AI-powered nurse staffing agent
- Patient involvement in life-shortening conditions: MND Insights
- NYU Langone Health says it received grand jury subpoena over gender-affirming care
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
- Health systems are exploring AI-powered cardiac risk screening. New CMS reimbursement could unlock a business case for it
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Most mental health practitioners satisfied with work, financially stable, SimplePractice finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Haleon tackles sports injuries with latest soccer play
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Eating Out Linked To Obesity Risk Worldwide
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
- Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
- Johnson & Johnson bladder cancer survey reveals toll of surgery, BCG treatment
- Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- Nearly 80% of payers prefer vendor-built AI solutions, survey finds
- University of California, union reach late-night deal to avert system-wide strike
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- ACA exchanges take spotlight in Q1
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- Watch: 8 Health Insurance Terms You Should Know
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Remarks at the Special Competitive Studies Project AI+ Expo
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
Can she be any worse than Rochelle Walensky?
CDC pick will find agency at a crossroadsPresident Biden has reportedly selected Mandy Cohen to lead the Centers for Disease Control and Prevention after Rochelle Walensky leaves this month.
Cohen, a former North Carolina health secretary, would inherit the role of CDC director as the agency finds itself under intense scrutiny for its public falterings in responding to COVID-19, especially for how it conveyed new information to the public.
Polls show public trust in the CDC has steadily declined, and congressional Republicans are likely going to question Cohen about the agency’s plans for change.
Walensky launched an overhaul of the CDC at the start of this year, and will leave before it’s finished.
While Walensky was an infectious disease doctor without much government experience, Cohen has plenty of government experience without an infectious disease background — something many outside health experts said they were hoping to see in the next CDC director.
Concerns around COVID-19 have largely faded into the background for many Americans, and experts have said government experience should take priority.
Cohen spent five years as North Carolina’s health secretary, helping the state pass Medicaid expansion and leading it through the height of the COVID-19 pandemic.
The CDC director won’t be a Senate-confirmed position until January 2025, so Cohen could presumably take over fairly quickly once she is formally announced.
Cohen also served in the Centers for Medicare and Medicaid Services during the Obama administration, helping to set up ObamaCare’s insurance exchanges and fix the disastrous rollout of Healthcare.gov, where she worked closely with current White House chief of staff Jeff Zients.
Major priorities for the agency include the reauthorization of a pandemic preparedness measure that expires on Sept. 30, as well as fiscal year 2024 appropriations.
Public health and research advocates have expressed concern that Republicans, angry at the agency for its COVID response, could try to cut funding.
"Major priorities for the agency include the reauthorization of a pandemic preparedness measure that expires on Sept. 30, as well as fiscal year 2024 appropriations."
Translation: they want power, and they want money.
She's a bureaucrat in charge of running a bureaucracy.... does anyone see any real change in this picture?
Why yes, she can be worse than Rochelle Walensky! 😏
From my hero, Alex Berenson:
https://alexberenson.substack.com/p/urgent-joe-biden-is-about-to-pick
URGENT: Joe Biden is about to pick the worst possible person to become the next CDC headAlex Berenson
June 2, 2023I'm not exaggerating. Dr. Mandy Cohen, the likely choice, is a public health Covid authoritarian and former chief of staff for censorer-in-chief Andy Slavitt.
Just what America needs.
Another Covid hysteric running the Centers for Disease Control.
Proving it has learned all the wrong lessons since 2021, the Biden Administration is about to choose Dr. Mandy Cohen to replace Dr. Rochelle Walensky as director of the Centers for Disease Control.
Cohen shares the same health authoritarian impulses as Walensky. She supported mask and vaccine mandates - and lockdowns even in 2021. But she is apparently more bureaucratically competent, and thus more dangerous, than Walensky.
Cohen is also very close to Andy Slavitt, whom I am suing in Berenson v Biden for his efforts to censor me. Her choice suggests Slavitt still has considerable influence in the Biden Administration two years after officially leaving the White House.
Apparently diversity mandates haven’t hit the CDC yet. Cohen is a lot like Walensky, a nice Jewish* doctor** from the Northeastern suburbs with all the right degrees.
(*I can say it, I’m Jewish)
(**The actual expression is “nice Jewish girl” but I don’t want to get in trouble)
Perhaps the biggest difference is that Cohen is less orange. Not figuratively, literally; Walensky’s skin tone occupies an uncanny valley somewhere between North Africa and Malibu Barbie. But I digress.
(Digression continues. What color is that? It’s not beige, it’s not orange, it’s not brown, it’s not white. Seriously, what color? Ecru? But is ecru a color, or just a world for beige at fancy furniture stores?)
I know, I shouldn’t make of Rochelle Walensky’s skin tone when there is SO MUCH ELSE to make fun her over.
Like that time she told Rachel Maddow that “vaccinated people do not carry the virus, don’t get sick.” Oops! Or the press conference where she said she was “scared” of Covid. Profiles In Courage, get me rewrite!
But wait. This piece isn’t about the departing CDC director, it’s about the incoming CDC director. The queen is dead, long live the queen.
Stunningly, despite their vast similarities in professional training and life experience, Cohen and Walensky have tons in common.
They both approached Covid by maximizing hysteria and government overreach. Like Walensky, Cohen loves her some face diapers.
In fact, she loves them more than Walensky. In December 2021, Cohen said that “everyone” needed to keep wearing masks. “Even if you’re vaccinated, you should wear a mask,” she said. Even the CDC had dropped its mask requirements for vaccinated people seven months before.
(No, seriously, she LOVES masks.
ALT: I got Tony Fauci sitting on my face. And he’s delicious!)
Besides pushing lockdowns through March 2021, Cohen also threatened legal action against a school district that wanted to drop quarantines and contact tracing - in September 2021, long after Covid’s lack of risk to school-age children became apparent. She pushed jab mandates for health care workers and explicitly tied loosening restrictions to vaccination levels.
In other words, Cohen has heartily supported every authoritarian measure that the last three years have proven useless. Of course, to the White House, her views are a feature, not a bug. And the Biden Administration seems to believe she will be able to make the CDC even more willing to follow its lead.
“White House officials were drawn to Cohen’s track record of leadership at the federal and state level, said people familiar with the process who spoke on the condition of anonymity,” the Washington Post reported. “That’s a stark contrast to Walensky, who was in her first leadership role in government.”
As Slavitt told the Post: “What the CDC needs now is what Mandy Cohen brings… I’ve worked with her as close as anyone and if she’s the choice, the country is in for a treat.”
Let’s all try not to choke.
Truly cringe-worthy!
Here's a palate-cleanser of sorts - ideas on how to limit the CDC.
https://brownstone.org/articles/the-cdc-as-we-know-it-has-to-go/
... Second, and more fundamentally, I wondered what structural reforms might turn the CDC into the agency that I had imagined before COVID. Here, my mind kept turning to thoughts about an agency that stands out as an example of good government: the National Transportation Safety Board. The NTSB is respected nationwide, and around the globe, for its skill, transparency, and reliability in investigating significant travel accidents, determining their causes, and proposing recommendations for new safety practices and regulations. The NTSB’s work has made enormous contributions to improvements in transportation safety over the years, and its reports can be real page-turners.A critical component to the NTSB’s success is that it has no regulatory authority. In 1967, Congress established it as an independent agency within the Department of Transportation. The idea was that “a single organization with a clearly defined mission could more effectively promote” transportation safety. However, Congress soon recognized that the only way to assure the NTSB’s independence was to move it outside of the DOT, so in 1974 Congress reestablished it as a separate agency.
Agencies charged with regulating transportation, such as the FAA, have to consider economic factors and the promotion of transportation in addition to safety. This cost/benefit responsibility can sometimes leave the FAA vulnerable to regulatory capture, as we saw with the 737-MAX catastrophe. The NTSB’s independence and its lack of regulatory authority, by contrast, give it the freedom to focus on fact-finding and to make recommendations, without being subjected to such pressures.
It would behoove Congress to consider a similar approach to restructuring the CDC. We need a federal public health agency that is just like the NTSB, one that is strictly charged with fact-finding and with making recommendations, but without any regulatory authority of its own. This would require moving the CDC out of HHS. The new CDC would have a limited role of investigating the causes and sources of infectious disease, and to make recommendations for how to address them, but without any regulatory authority that, as we have learned, could subject the agency to political pressure and regulatory capture.
Consider the fact that we still do not know for certain where COVID originated. Was it a lab leak, or the result of zoonosis? The NIH, which funded risky gain of function research in Wuhan, is also part of HHS. Had the CDC been taken out of HHS and given independent investigative powers, including the power to audit HHS’s research funding practices, there is a fair chance that we would know the answer to that. We would also likely have a series of dispassionate recommendations on what to do about preventing future occurrences.
If COVID proved anything, it is that we desperately need a federal agency like this. If Congress is serious about restoring trust in public health, it would do well to consider such a reform.
Brant C. Hadaway is a seasoned, bilingual (English/Czech) attorney focusing his practice on international commercial disputes, contracts, and regulatory compliance on behalf of foreign and domestic clients in the U.S. and abroad.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















